Show simple item record

dc.creatorYegla, B
dc.creatorParikh, V
dc.date.accessioned2021-01-29T22:06:42Z
dc.date.available2021-01-29T22:06:42Z
dc.date.issued2015-01-28
dc.identifier.issn1662-5137
dc.identifier.issn1662-5137
dc.identifier.doihttp://dx.doi.org/10.34944/dspace/5223
dc.identifier.otherPMC4309160 (pmc)
dc.identifier.urihttp://hdl.handle.net/20.500.12613/5241
dc.format.extent254-
dc.language.isoeng
dc.relation.haspartFrontiers in Systems Neuroscience
dc.relation.isreferencedbyFrontiers Media SA
dc.rightsCC BY
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectAlzheimer's disease
dc.subjectacetylcholine
dc.subjectacetylcholinesterase (AChE) inhibitor
dc.subjectcognition
dc.subjectneurotrophins
dc.titleRejuvenating procholinergic treatments for cognition enhancement in AD current challenges and future prospects
dc.typeArticle
dc.type.genreJournal Article
dc.relation.doi10.3389/fnsys.2014.00254
dc.ada.noteFor Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
dc.creator.orcidParikh, Vinay|0000-0001-5213-5490
dc.date.updated2021-01-29T22:06:39Z
refterms.dateFOA2021-01-29T22:06:43Z


Files in this item

Thumbnail
Name:
Rejuvenating procholinergic ...
Size:
646.1Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

CC BY
Except where otherwise noted, this item's license is described as CC BY